Al18F-NOTA-Pentixafor

N/A

Report date: 2025/11/20 11:38:27

NME

Base Information

Drug NameAl18F-NOTA-Pentixafor

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC) +[4]

Mechanisms of ActionC-X-C motif chemokine receptor 4 modulators

TargetsC-X-C motif chemokine receptor 4

Therapy Area/IndicationsHyperaldosteronism

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesPeking Union Medical College Hospital

China Registration ClassN/A

Develop Information

Active CompaniesPeking Union Medical College Hospital

Inactive CompaniesN/A

Active IndicationsHyperaldosteronism

Inactive IndicationsN/A

Other Information

ATC CodeN/A